logo
Global Markets Mixed; Treasury Yields Fall as Expectations for Interest-Rate Cut Mount

Global Markets Mixed; Treasury Yields Fall as Expectations for Interest-Rate Cut Mount

Stock markets broadly fell back Thursday after recent gains. U.S. stock futures were flat to marginally down, Asian markets closed lower but European bourses eked out small gains.
Treasury yields fell to their lowest level in a week as investors increasingly bet that the Federal Reserve will cut interest rates in September which is also putting pressure on the dollar.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Asian Market Highlights: Penny Stocks To Watch In August 2025
Asian Market Highlights: Penny Stocks To Watch In August 2025

Yahoo

time16 minutes ago

  • Yahoo

Asian Market Highlights: Penny Stocks To Watch In August 2025

As global markets navigate a landscape marked by shifting trade policies and monetary adjustments, the Asian market continues to capture attention with its diverse economic activities and robust stock performances. Amidst this backdrop, penny stocks—though an older term—remain a focal point for investors seeking potential growth in smaller or newer companies. By identifying those with strong financial health, investors can uncover opportunities that balance risk with promising returns. Top 10 Penny Stocks In Asia Name Share Price Market Cap Financial Health Rating Food Moments (SET:FM) THB4.30 THB4.25B ★★★★★☆ JBM (Healthcare) (SEHK:2161) HK$2.86 HK$2.33B ★★★★★★ Lever Style (SEHK:1346) HK$1.48 HK$915.41M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.52 HK$2.1B ★★★★★★ China Sunsine Chemical Holdings (SGX:QES) SGD0.68 SGD648.3M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.88 SGD11.33B ★★★★★☆ Ekarat Engineering (SET:AKR) THB0.95 THB1.4B ★★★★★★ Livestock Improvement (NZSE:LIC) NZ$0.95 NZ$135.23M ★★★★★★ Rojana Industrial Park (SET:ROJNA) THB4.82 THB9.74B ★★★★★★ BRC Asia (SGX:BEC) SGD3.55 SGD973.94M ★★★★★★ Click here to see the full list of 977 stocks from our Asian Penny Stocks screener. Let's review some notable picks from our screened stocks. K. Wah International Holdings Simply Wall St Financial Health Rating: ★★★★★★ Overview: K. Wah International Holdings Limited is an investment holding company involved in property development and investment in Hong Kong and Mainland China, with a market capitalization of approximately HK$7.79 billion. Operations: The company's revenue is primarily derived from property development in Mainland China (HK$5.91 billion) and Hong Kong (HK$540.49 million), along with property investment generating HK$642.97 million. Market Cap: HK$7.79B K. Wah International Holdings, with a market capitalization of HK$7.79 billion, derives substantial revenue from property development in Mainland China and Hong Kong. It has managed to reduce its debt-to-equity ratio over the past five years, maintaining a satisfactory net debt level relative to equity. The company's short-term assets significantly exceed both its short- and long-term liabilities, reflecting strong liquidity. However, recent earnings have declined sharply by 58.2%, with forecasts indicating further declines over the next three years. Despite trading below estimated fair value, its return on equity remains low at 0.9%, and dividend stability is uncertain due to an unstable track record. Click here and access our complete financial health analysis report to understand the dynamics of K. Wah International Holdings. Learn about K. Wah International Holdings' future growth trajectory here. China Shanshui Cement Group Simply Wall St Financial Health Rating: ★★★★★☆ Overview: China Shanshui Cement Group Limited is an investment holding company that manufactures and sells cement, clinker, concrete, and related products and services in the People's Republic of China, with a market cap of HK$3.83 billion. Operations: The company generates CN¥13.50 billion in revenue from its operations in manufacturing and trading cement, clinker, and concrete. Market Cap: HK$3.83B China Shanshui Cement Group has seen a volatile share price recently, reflecting broader challenges in the sector. Despite becoming profitable last year, its earnings have been impacted by large one-off items and declining sales, with recent half-year revenue at CN¥5.55 billion compared to CN¥6.57 billion previously. The company reported a net loss of CN¥250 million for the same period but has improved from a larger loss last year. Its debt management is prudent with a satisfactory net debt to equity ratio of 13.2%, though short-term liabilities exceed assets, posing potential liquidity concerns amidst ongoing legal issues and governance changes. Click here to discover the nuances of China Shanshui Cement Group with our detailed analytical financial health report. Explore historical data to track China Shanshui Cement Group's performance over time in our past results report. Fuan Pharmaceutical (Group) Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Fuan Pharmaceutical (Group) Co., Ltd. is engaged in the research, development, production, and sale of chemical drugs in China with a market cap of CN¥5.85 billion. Operations: The company generates CN¥2.05 billion in revenue from its pharmaceutical industry segment. Market Cap: CN¥5.85B Fuan Pharmaceutical (Group) Co., Ltd. offers a stable investment profile within the penny stock segment, with its CN¥2.05 billion revenue from pharmaceuticals and a market cap of CN¥5.85 billion. The company boasts seasoned management and board teams, with average tenures of 14.3 and 3.7 years respectively, supporting strategic continuity. Short-term assets comfortably cover both short- and long-term liabilities, while operating cash flow adequately covers debt obligations at 20%. Despite negative earnings growth last year, profit margins improved to 11% from 9.7%, indicating operational resilience amid challenges in the broader pharmaceutical industry landscape. Navigate through the intricacies of Fuan Pharmaceutical (Group) with our comprehensive balance sheet health report here. Gain insights into Fuan Pharmaceutical (Group)'s past trends and performance with our report on the company's historical track record. Seize The Opportunity Click through to start exploring the rest of the 974 Asian Penny Stocks now. Interested In Other Possibilities? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 27 best rare earth metal stocks of the very few that mine this essential strategic resource. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:173 SEHK:691 and SZSE:300194. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@

Bell Food Group First Half 2025 Earnings: EPS: CHF7.29 (vs CHF7.22 in 1H 2024)
Bell Food Group First Half 2025 Earnings: EPS: CHF7.29 (vs CHF7.22 in 1H 2024)

Yahoo

time16 minutes ago

  • Yahoo

Bell Food Group First Half 2025 Earnings: EPS: CHF7.29 (vs CHF7.22 in 1H 2024)

Explore Bell Food Group's Fair Values from the Community and select yours Bell Food Group (VTX:BELL) First Half 2025 Results Key Financial Results Revenue: CHF2.40b (up 3.7% from 1H 2024). Net income: CHF45.7m (flat on 1H 2024). Profit margin: 1.9% (down from 2.0% in 1H 2024). The decrease in margin was driven by higher expenses. EPS: CHF7.29 (up from CHF7.22 in 1H 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Bell Food Group Earnings Insights Looking ahead, revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 2.7% growth forecast for the Food industry in Switzerland. Performance of the Swiss Food industry. The company's share price is broadly unchanged from a week ago. Risk Analysis You should learn about the 2 warning signs we've spotted with Bell Food Group. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Gesco Second Quarter 2025 Earnings: EPS Beats Expectations
Gesco Second Quarter 2025 Earnings: EPS Beats Expectations

Yahoo

time16 minutes ago

  • Yahoo

Gesco Second Quarter 2025 Earnings: EPS Beats Expectations

Gesco (ETR:GSC1) Second Quarter 2025 Results Key Financial Results Revenue: €118.2m (down 8.2% from 2Q 2024). Net income: €2.52m (up by €2.29m from 2Q 2024). Profit margin: 2.1% (up from 0.2% in 2Q 2024). The increase in margin was driven by lower expenses. EPS: €0.24 (up from €0.022 in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Gesco EPS Beats Expectations Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 10.0%. Looking ahead, revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Machinery industry in Germany. Performance of the German Machinery industry. The company's shares are up 1.7% from a week ago. Balance Sheet Analysis Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on Gesco's balance sheet health. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store